The Peptide Wiki
Mapping Knowledge.
Advancing Discovery.
// STATE LEGISLATION TRACKER

South Carolina H4189: DHEC Restructuring

โš–๏ธ NEUTRAL for peptide users ๐Ÿ‘ค NONE user impact ๐Ÿ“œ Status: Signed
State
South Carolina
Bill
H4189
Session
2025-2026
Filed
2025-03-20
Read the bill
OpenStates โ†’
Last reviewed
2026-10-02

Plain-English Summary

South Carolina H4189 is a DHEC restructuring cleanup bill. It appears to update agency names and duties after the former DHEC was split, with no direct peptide-ecosystem relevance found from the title, status, and available bill text.

Key Points

  • No peptide-specific language found in the available bill text.
  • No apparent change to compounded peptides or FDA 503A/503B rules.
  • No apparent change to off-label prescribing for peptides.
  • No apparent expansion or restriction of telehealth peptide care.
  • Controlled-substance references appear to be agency-update language.

What to Watch For

i
Note Clinics and pharmacies may need to update compliance references from DHEC to the new public health agency names.
i
Note Controlled-substance registration language points to the renamed public health department, not a new peptide rule.
i
Note Any practical effect would likely come from later agency forms, regulations, or guidance, not this bill itself.

Where the Bill Stands

The bill was signed by the Governor on May 15, 2026 and became Act No. 146 on May 26, 2026.
ยท Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.
Bill page generated 2026-11-04 ยท enriched via codex gpt-5.5
Source: OpenStates v3 API ยท View official bill ยท โ† back to all laws